Soumendu Patra

Mr. Soumendu Patra

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SPSoumendu Patra
Soumendu Patra
HSHarshita Shand
Harshita Shand
SGSayan Ghosal
Sayan Ghosal
SGSuvankar Ghorai
Suvankar Ghorai
Human papillomavirus (HPV) infection poses significant public health issues for both men and women. Recent studies have brought attention to the substantial impact of HPV-linked cancers in men despite historically focusing more on its effects on women. It was revealed that in 2019, HPV was the root cause of approximately 70,000 cancer cases in men. Modes of transmission for HPV include sexual contact, encompassing various practices such as vaginal, anal, and oral intercourse, as well as the use of sexual devices. Moreover, HPV-associated cancers are becoming increasingly common in men, with anal, penile, and oral cancers being the most prevalent. Although the human body can clear HPV infection in about 90% of cases, it’s crucial to take preventive measures to lower the risk of transmission and developing cancer. Using condoms, quitting smoking, and male circumcision are identified as essential factors in preventing HPV among heterosexual couples. However, the most promising preventive measure is HPV vaccination. There are ongoing discussions regarding its protective efficacy and cost-effectiveness; vaccinating boys before their sexual debut presents a compelling rationale. The existing literature primarily focuses on HPV-linked cancer in women and lacks a comprehensive review of the development and prevention methods specifically related to HPV-related cancers in men. This review strives to bridge this gap by offering a detailed overview of HPV-linked cancers in males, particularly anal, penile, and head & neck cancer. It will cover important aspects of prevention and treatment strategies to provide valuable information for public health initiatives and clinical practice.

4 November 2023 in Human Immunology
Verified
Journal Article
Closed access
SPSoumendu Patra
Soumendu Patra
SGSayan Ghosal
Sayan Ghosal
HSHarshita Shand
Harshita Shand
RMRittick Mondal
Rittick Mondal
ARAnkita Rath
Ankita Rath
SGSuvankar Ghorai
Suvankar Ghorai

16 March 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGSuvankar Ghorai
Suvankar Ghorai
HSHarshita Shand
Harshita Shand
SPSoumendu Patra
Soumendu Patra
Kingshuk PandaKingshuk Panda
Kingshuk Panda
MSMaria Jose Santiago
Maria Jose Santiago
HUHoshang Unwalla
Hoshang Unwalla
The continuous evolution of new viruses poses a danger to world health. Rampant outbreaks may advance to pandemic level, often straining financial and medical resources to breaking point. While vaccination remains the gold standard to prevent viral illnesses, these are mostly prophylactic and offer minimal assistance to those who have already developed viral illnesses. Moreover, the timeline to vaccine development and testing can be extensive, leading to a lapse in controlling the spread of viral infection during pandemics. Antiviral therapeutics can provide a temporary fix to tide over the time lag when vaccines are not available during the commencement of a disease outburst. At times, these medications can have negative side effects that outweigh the benefits, and they are not always effective against newly emerging virus strains. Several limitations with conventional antiviral therapies may be addressed by nanotechnology. By using nano delivery vehicles, for instance, the pharmacokinetic profile of antiviral medications can be significantly improved while decreasing systemic toxicity. The virucidal or virus-neutralizing qualities of other special nanomaterials can be exploited. This review focuses on the recent advancements in nanomedicine against RNA viruses, including nano-vaccines and nano-herbal therapeutics.

4 September 2023 in Applied Nanoscience
Verified
Journal Article
Closed access
HSHarshita Shand
Harshita Shand
SDSwarnab Dutta
Swarnab Dutta
SPSoumendu Patra
Soumendu Patra
HJHarshil Jain
Harshil Jain
RMRittick Mondal
Rittick Mondal
SGSuvankar Ghorai
Suvankar Ghorai

28 April 2025 in Next Materials
Verified
Journal Article
Open access
SPSoumendu Patra
Soumendu Patra
HSHarshita Shand
Harshita Shand
SGSayan Ghosal
Sayan Ghosal
SGSuvankar Ghorai
Suvankar Ghorai

28 May 2026 in Discover Sensors
Verified
Journal Article
Open access
PDF file
SPSoumendu Patra
Soumendu Patra
HSHarshita Shand
Harshita Shand
Quantum dot (QD)-based biosensors have become a promising platform for biomedical diagnostics, particularly for early disease detection, where conventional immunoassays often struggle with low sensitivity, photobleaching, and poor optical penetration in biological tissues. QDs overcome these limitations through exceptional photostability, size-dependent emission tunability, and high quantum yield, enabling reliable detection even at ultralow biomarker levels. Their surface chemistry can be precisely engineered to attach antibodies, aptamers, peptides, or nucleic acids, supporting a wide range of selective and multiplexed sensing formats. QDs capable of near-infrared (NIR) emission further enhance clinical applicability by reducing tissue autofluorescence and improving in vivo imaging depth for real-time molecular tracking. This review highlights recent advances in QD-based fluorescent, photoelectrochemical, and electrochemiluminescent biosensors, emphasising their operating principles, analytical performance, and utility in detecting pathogens, cancer biomarkers, metabolites, and other clinically relevant targets. Challenges, including toxicity, biocompatibility, and biodistribution, are discussed alongside emerging solutions such as surface passivation, cadmium-free compositions, and biocompatible coatings. Unlike existing reviews, this article provides a mechanistic and integrated perspective by linking quantum dot surface engineering with sensing mechanisms and their clinical translational relevance, offering a unified framework for next-generation diagnostic development.